Abstract:Background High blood pressure is a prognostic factor for acute stroke, but blood pressure variability might also independently predict outcome. We assessed the prognostic value of blood pressure variability in participants of INTERACT2, an open-label randomised controlled trial (ClinicalTrials.gov number NCT00716079).Methods INTERACT2 enrolled 2839 adults with spontaneous intracerebral haemorrhage (ICH) and high systolic blood pressure (150-220 mm Hg) without a definite indication or contraindication to early intensive treatment to reduce blood pressure. Participants were randomly assigned to intensive treatment (target systolic blood pressure <140 mm Hg within 1 h using locally available intravenous drugs) or guideline-recommended treatment (target systolic blood pressure <180 mm Hg) within 6 h of onset of ICH. The primary outcome was death or major disability at 90 days (modified Rankin Scale score >= 3) and the secondary outcome was an ordinal shift in modified Rankin Scale scores at 90 days, assessed by investigators masked to treatment allocation. Blood pressure variability was defined according to standard criteria: five measurements were taken in the first 24 h (hyperacute phase) and 12 over days 2-7 (acute phase). We estimated associations between blood pressure variability and outcomes with logistic and proportional odds regression models. The key parameter for blood pressure variability was standard deviation (SD) of systolic blood pressure, categorised into quintiles.Findings We studied 2645 (93.2%) participants in the hyperacute phase and 2347 (82.7%) in the acute phase. In both treatment cohorts combined, SD of systolic blood pressure had a significant linear association with the primary outcome for both the hyperacute phase (highest quintile adjusted OR 1.41, 95% CI 1.05-1.90; p(trend)=0.0167) and the acute phase (highest quintile adjusted OR 1.57, 95% CI 1.14-2.17; p(trend)=0.0124). The strongest predictors of outcome were maximum systolic blood pressure in the hyperacute phase and SD of systolic blood pressure in the acute phase. Associations were similar for the secondary outcome (for the hyperacute phase, highest quintile adjusted OR 1.43, 95% CI 1.14-1.80; p(trend)=0.0014; for the acute phase OR 1.46, 95% CI 1.13-1.88; p(trend)=0.0044).Interpretation Systolic blood pressure variability seems to predict a poor outcome in patients with acute intracerebral haemorrhage. The benefits of early treatment to reduce systolic blood pressure to 140 mm Hg might be enhanced by smooth and sustained control, and particularly by avoiding peaks in systolic blood pressure.Funding National Health and Medical Research Council of Australia.

Statistical Analysis Plan for the INTEnsive care bundle with blood pressure Reduction in Acute Cerebral haemorrhage Trial (INTERACT3)

Statistical Analysis Plan for the Second Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2)

The Second (main) Phase of an Open, Randomised, Multicentre Study to Investigate the Effectiveness of an Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (Interact2)

Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT): a Randomised Pilot Trial

INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trial

Process Evaluation of an Ambulance-delivered Early Intensive Blood Pressure Lowering Stroke Trial: Design, Rationale, and Reflection

Statistical analysis plan for the Chinese Herbal medicine in Acute INtracerebral haemorrhage (CHAIN) trial

OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE.

Optimal Achieved Blood Pressure in Acute Intracerebral Hemorrhage: INTERACT2.

Effects Of Early Intensive Blood Pressure-Lowering Treatment On The Growth Of Hematoma And Perihematomal Edema In Acute Intracerebral Hemorrhage The Intensive Blood Pressure Reduction In Acute Cerebral Haemorrhage Trial (Interact)

Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial

Statistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial

Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies.

Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.

Associations of an Abnormal Physiological Score With Outcomes in Acute Intracerebral Hemorrhage: INTERACT2 Study.

Blood Pressure Variability and Outcome after Acute Intracerebral Haemorrhage : a Post-Hoc Analysis of INTERACT 2 , a Randomised Controlled Trial *

Clinical Prediction Algorithm (BRAIN) to Determine Risk of Hematoma Growth in Acute Intracerebral Hemorrhage

Predictive Accuracy of Clinicians Estimates of Death and Recovery after Acute Intracerebral Hemorrhage: Pre-Specified Analysis in INTERACT3 Study

Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants